118 related articles for article (PubMed ID: 9263396)
1. Chimeric fibrolase: covalent attachment of an RGD-like peptide to create a potentially more effective thrombolytic agent.
Sanchez EF; Bush LR; Swenson S; Markland FS
Thromb Res; 1997 Aug; 87(3):289-302. PubMed ID: 9263396
[TBL] [Abstract][Full Text] [Related]
2. Chimeric derivative of fibrolase, a fibrinolytic enzyme from southern copperhead venom, possesses inhibitory activity on platelet aggregation.
Swenson S; Bush LR; Markland FS
Arch Biochem Biophys; 2000 Dec; 384(2):227-37. PubMed ID: 11368309
[TBL] [Abstract][Full Text] [Related]
3. Modular design, expression and characterization of novel bifunctional mutants of fibrolase with combined platelet aggregation-inhibition and fibrinolytic activity.
Fang HM; Zhao L; Lu P; Chen SJ; Bao ZX; Qin YF; Zhu ZY; Zhao JM; Mai J; Zhang ST
Protein J; 2011 Apr; 30(4):247-52. PubMed ID: 21479991
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of fibrolase isoforms from venom of individual southern copperhead (Agkistrodon contortrix Contortrix) snakes.
Trikha M; Schmitmeier S; Markland FS
Toxicon; 1994 Dec; 32(12):1521-31. PubMed ID: 7725320
[TBL] [Abstract][Full Text] [Related]
5. Fibrolase: trials and tribulations.
Markland FS; Swenson S
Toxins (Basel); 2010 Apr; 2(4):793-808. PubMed ID: 22069611
[TBL] [Abstract][Full Text] [Related]
6. Alpha-fibrinogenases.
Swenson S; Toombs CF; Pena L; Johansson J; Markland FS
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Dec; 4(4):417-35. PubMed ID: 15578961
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characteristics of fibrolase, a fibrinolytic protease from snake venom.
Ahmed NK; Tennant KD; Markland FS; Lacz JP
Haemostasis; 1990; 20(3):147-54. PubMed ID: 1696922
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel bifunctional mutant of staphylokinase with platelet-targeted thrombolysis and antiplatelet aggregation activities.
Chen H; Mo W; Su H; Zhang Y; Song H
BMC Mol Biol; 2007 Oct; 8():88. PubMed ID: 17919340
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional structure of fibrolase, the fibrinolytic enzyme from southern copperhead venom, modeled from the X-ray structure of adamalysin II and atrolysin C.
Bolger MB; Swenson S; Markland FS
AAPS PharmSci; 2001; 3(2):E16. PubMed ID: 11741267
[TBL] [Abstract][Full Text] [Related]
10. Thrombolytic agents in development.
Verstraete M; Lijnen HR; Collen D
Drugs; 1995 Jul; 50(1):29-42. PubMed ID: 7588087
[TBL] [Abstract][Full Text] [Related]
11. Biological and thrombolytic properties of fibrolase--a new fibrinolytic protease from snake venom.
Ahmed NK; Gaddis RR; Tennant KD; Lacz JP
Haemostasis; 1990; 20(6):334-40. PubMed ID: 2099322
[TBL] [Abstract][Full Text] [Related]
12. Sequence analysis of fibrolase, a fibrinolytic metalloproteinase from Agkistrodon contortrix contortrix.
Manning MC
Toxicon; 1995 Sep; 33(9):1189-200. PubMed ID: 8585089
[TBL] [Abstract][Full Text] [Related]
13. Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis.
Markland FS; Friedrichs GS; Pewitt SR; Lucchesi BR
Circulation; 1994 Nov; 90(5):2448-56. PubMed ID: 7955202
[TBL] [Abstract][Full Text] [Related]
14. Functional properties of a recombinant chimeric plasminogen activator with platelet-targeted fibrinolytic and anticoagulant potential.
Zhang L; Wang J; Yu M; Ru B
Mol Genet Metab; 2004 Aug; 82(4):304-11. PubMed ID: 15308128
[TBL] [Abstract][Full Text] [Related]
15. Cyclic RGD peptide analogues as antiplatelet antithrombotics.
Barker PL; Bullens S; Bunting S; Burdick DJ; Chan KS; Deisher T; Eigenbrot C; Gadek TR; Gantzos R; Lipari MT
J Med Chem; 1992 May; 35(11):2040-8. PubMed ID: 1597855
[TBL] [Abstract][Full Text] [Related]
16. Resolution of isoforms of natural and recombinant fibrolase, the fibrinolytic enzyme from Agkistrodon contortrix contortrix snake venom, and comparison of their EDTA sensitivities.
Loayza SL; Trikha M; Markland FS; Riquelme P; Kuo J
J Chromatogr B Biomed Appl; 1994 Dec; 662(2):227-43. PubMed ID: 7719479
[TBL] [Abstract][Full Text] [Related]
17. Expression of soluble and functional snake venom fibrinolytic enzyme fibrolase via the co-expression of DsbC in Escherichia coli.
Zhang ST; Shi J; Zhao J; Qi YF; Guo AG
Protein Pept Lett; 2006; 13(6):559-63. PubMed ID: 16842109
[TBL] [Abstract][Full Text] [Related]
18. Novel recombinant thrombolytic and antithrombotic staphylokinase variants with an RGD motif at their N-termini.
He J; Di J; Xu R; Zhao B
Biotechnol Appl Biochem; 2008 May; 50(Pt 1):17-23. PubMed ID: 18039183
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of AHPM, a novel non-hemorrhagic P-IIIc metalloproteinase with α-fibrinogenolytic and platelet aggregation-inhibition activities, from Agkistrodon halys pallas venom.
Song J; Xu X; Zhang Y; Guo M; Yan X; Wang S; Gao S
Biochimie; 2013 Apr; 95(4):709-18. PubMed ID: 23104267
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of an Asp-Ser sequence to form an RGDS-like motif in hirutonin: the effect on in vitro platelet function.
van Wyk V; Leblond L; Winocour PD; Devine DV; Gyongyossy-Issa MI
Thromb Res; 2000 Aug; 99(4):343-52. PubMed ID: 10963785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
